Back to Journals » OncoTargets and Therapy » Volume 14

Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLC

Total article views   HTML views PDF downloads Totals
6,350 Dovepress* 5,548+ 603 6,151
PubMed Central* 802 150 952
Totals 6,350 753 7,103
*Since 25 May 2021
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 1 3 5

View citations on PubMed and Google Scholar